NewBiologix

Recent Finacing

Series A

Recent Raise

$50.4M

NewBiologix develops a DNA-based platform combining NGS genome characterization and bioinformatics to engineer HEK-293 and CHO cell lines for stable, predictable, low-empty-capsid rAAV vector manufacturing.

Founded 2023

Vaud, Switzerland

11-50

Private

newbiologix.com

Highlights

Focus Areas

Biotechnology

Health Care

Life Science

Medical

Recent Investors

Financials

$50.4M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at NewBiologix.